Cote d'Ivoire vs Ukraine: The number of people with susceptibility test result for rifampicin
Cote d'Ivoire
8,494
in 2021
Ukraine
9,237
in 2021
Cote d'Ivoire rank
25th
Ukraine rank
23rd
The number of people with susceptibility test result for rifampicin over time
- Cote d'Ivoire
- Ukraine
How they compare
Ukraine currently reports 9,237 against 8,494 in Cote d'Ivoire, a difference of 743.
That makes Ukraine's figure about 1.1 times Cote d'Ivoire's.
Across all 5 years both countries report, Ukraine has been ahead every year.
Cote d'Ivoire ranks 25th and Ukraine ranks 23rd of 155 countries.
Ukraine has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3,175 | 12,368 | 9,193 | Ukraine |
| 2020s | 4,890 | 9,015 | 4,126 | Ukraine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cote d'Ivoire or Ukraine?
- Ukraine, at 9,237 against 8,494 in Cote d'Ivoire as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cote d'Ivoire and Ukraine?
- 743, with Ukraine ahead.
- How many years of comparable data are there for Cote d'Ivoire and Ukraine?
- 5 years are reported by both, from 2017 to 2021.
- How do Cote d'Ivoire and Ukraine rank globally for the number of people with susceptibility test result for rifampicin?
- Cote d'Ivoire ranks 25th and Ukraine ranks 23rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.